Remodeling of Central Metabolism in Invasive Breast Cancer Compared to Normal Breast Tissue

News   Sep 07, 2012

 
Remodeling of Central Metabolism in Invasive Breast Cancer Compared to Normal Breast Tissue
 
 
 

RELATED ARTICLES

BIA Separations appoints Pete Gagnon as Chief Scientific Officer

News

Appointment will drive new product and applications development.

READ MORE

Protein's Role in Mitochondrial Metabolism Identified

News

EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE